Recent Updates
Recently added Catalysts
GEHC Positive Sentiment

GE HealthCare appoints veteran finance executive Pascal Desroches to Board of Directors

Tuesday, September 22, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: GE HealthCare has appointed Pascal Desroches, CFO of AT&T, to its Board of Directors, effective January 4, 2027. Desroches has over 30 years of experience in finance and governance, which is expected to significantly benefit the company. His expertise in large-scale technology and digital transformation will be a valuable asset.

Market Sentiment Analysis

POSITIVE FACTORS

  • Pascal Desroches brings over 30 years of leadership experience.
  • His appointment is expected to enhance GE HealthCare's governance.
  • Desroches has a strong background in finance and digital transformation.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+32%
120-day peak, hindsight
Typical move
2.5%
average across 3 past catalysts
Lead asset
PET MPI
Phase 3 · Coronary Artery Disease (CAD)

Full Press Release Details

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced the appointment of Pascal Desroches, Senior Executive Vice President and Chief Financial Officer (CFO) of AT&T (NYSE: T), a Fortune 50 company, to its Board of Directors, effective January 4, 2027. Mr. Desroches brings more than 30 years of leadership experience across finance, governance, and large-scale technology and digital transformation.“Pascal is a highly respected executive and accomplished financial leader whose

Frequently Asked Questions

Who is Pascal Desroches?

Pascal Desroches is the CFO of AT&T and has over 30 years of leadership experience.

When will Pascal Desroches join GE HealthCare's Board?

He will join the Board of Directors on January 4, 2027.

What experience does Desroches bring?

He brings extensive experience in finance, governance, and digital transformation.

Why is Desroches' appointment significant?

His expertise is expected to enhance GE HealthCare's governance and strategic direction.

ShareAdd on Google
Tags: GEHC Viatris Investor Conferences Healthcare GE HealthCare Pascal Desroches Board of Directors CFO AT&T
Last updated: Sep 22, 2026

Biotech snapshot

Cash runway
$2079M liquidity · $0M/mo burn
Low dilution risk
Lead asset
PET MPIPhase 3
Coronary Artery Disease (CAD) →

Catalyst track record

+32%
best trade around GEHC's most recent catalyst

Peak hindsight return over a 120-day window, across 3 tracked FDA/PDUFA catalysts for GEHC.

See every catalyst's timing & PoA →